FI920425A0 - Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel. - Google Patents

Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.

Info

Publication number
FI920425A0
FI920425A0 FI920425A FI920425A FI920425A0 FI 920425 A0 FI920425 A0 FI 920425A0 FI 920425 A FI920425 A FI 920425A FI 920425 A FI920425 A FI 920425A FI 920425 A0 FI920425 A0 FI 920425A0
Authority
FI
Finland
Prior art keywords
framstaellning
image
deras
cycloalkylenazoler
laekemedel
Prior art date
Application number
FI920425A
Other languages
English (en)
Finnish (fi)
Inventor
Rolf Bohlmann
Peter Strehlke
David Henderson
Martin Schneider
Yukishige Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI920425A0 publication Critical patent/FI920425A0/fi
Priority to FI970166A priority Critical patent/FI970166A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI920425A 1989-08-04 1992-01-30 Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel. FI920425A0 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI970166A FI970166A0 (fi) 1989-08-04 1997-01-15 Sykloalkyleeniatsoleja, menetelmä niiden valmistamiseksi ja niitä sisältäviä ehkäisyainevalmisteita

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
PCT/DE1990/000611 WO1991001975A1 (de) 1989-08-04 1990-08-06 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische präparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
FI920425A0 true FI920425A0 (fi) 1992-01-30

Family

ID=6386820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920425A FI920425A0 (fi) 1989-08-04 1992-01-30 Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.

Country Status (19)

Country Link
US (3) US5135937A (ja)
EP (1) EP0411735B1 (ja)
JP (1) JP3207417B2 (ja)
CN (1) CN1024345C (ja)
AT (1) ATE122662T1 (ja)
AU (1) AU634266B2 (ja)
CA (1) CA2022682C (ja)
DD (1) DD296917A5 (ja)
DE (2) DE3926365A1 (ja)
DK (1) DK0411735T3 (ja)
ES (1) ES2074530T3 (ja)
FI (1) FI920425A0 (ja)
HU (2) HU217126B (ja)
IE (1) IE902843A1 (ja)
IL (1) IL95279A (ja)
NO (1) NO301115B1 (ja)
PT (1) PT94884B (ja)
WO (1) WO1991001975A1 (ja)
ZA (1) ZA906150B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (ja) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
WO2001012206A2 (de) * 1999-08-13 2001-02-22 Heinrich Wieland Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen
WO2007100346A1 (en) * 2005-07-06 2007-09-07 Sicor, Inc. Improved process for the preparation of letrozole
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
NO920432D0 (no) 1992-02-03
AU6019490A (en) 1991-02-07
EP0411735B1 (de) 1995-05-17
HU9200324D0 (en) 1992-04-28
CN1024345C (zh) 1994-04-27
IE902843A1 (en) 1991-02-27
NO301115B1 (no) 1997-09-15
EP0411735A1 (de) 1991-02-06
US5135937A (en) 1992-08-04
HUT59911A (en) 1992-07-28
HU217126B (hu) 1999-11-29
DK0411735T3 (da) 1995-10-16
NO920432L (no) 1992-02-03
ATE122662T1 (de) 1995-06-15
AU634266B2 (en) 1993-02-18
US5280035A (en) 1994-01-18
CA2022682A1 (en) 1991-02-05
JP3207417B2 (ja) 2001-09-10
IL95279A (en) 1995-03-30
WO1991001975A1 (de) 1991-02-21
IL95279A0 (en) 1991-06-30
PT94884B (pt) 1997-04-30
DE3926365A1 (de) 1991-02-07
CN1049157A (zh) 1991-02-13
DD296917A5 (de) 1991-12-19
DE59009084D1 (de) 1995-06-22
ES2074530T3 (es) 1995-09-16
ZA906150B (en) 1991-05-29
CA2022682C (en) 1997-01-21
PT94884A (pt) 1991-04-18
JPH05501104A (ja) 1993-03-04
US5411982A (en) 1995-05-02

Similar Documents

Publication Publication Date Title
GEP20094816B (en) Morpholinoethylester of mycophenolic acid and derivatives thereof, their preparation and use in pharmaceutical compositions
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
HUP9902121A2 (hu) Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
NO810478L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
FI920425A0 (fi) Cykloalkylenazoler, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat och deras anvaendning vid framstaellning av laekemedel.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
NO158017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
ES484718A1 (es) Un procedimiento para la preparacion de benzopiranos.
IE43278L (en) Diphenyl sulfides.
JPS52106897A (en) Synthesis of piperazine derivatives
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
GB1141936A (en) Improvements in or relating to benzimidazole derivatives
EP0066909A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and processes for their production
ES8307224A1 (es) Un metodo para preparar derivados de pirazolina.
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
ATE53030T1 (de) Verbindung mit entzuendungshemmender wirkung, verfahren zu ihrer herstellung und pharmazeutische praeparate die sie enthalten.
US4247554A (en) Method for the prevention of gastro-intestinal ulcer caused by a non-steroidal anti-inflammatory agent
FI896228A0 (fi) Analogiamenetelmä valmistaa lääkeaineina käyttökelpoisia uusia karboksimidiamidijohdannaisia tai niiden farmaseuttisesti sopivia happoadditiosuoloja
DE3367209D1 (en) Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them
CA1062615A (en) Method for the prevention of gastro-intestinal ulcer caused by a non-steroidal anti-inflammatory agent
GB1434645A (en) Tetrazole coumarin derivatives